文献速递神经胸部MR

基于多模态MRI的影像组学方法预测肺癌脑转移瘤对伽玛刀放射外科治疗的反应

Multimodality MRI-based radiomics approach to predict the posttreatment response of lung cancer brain metastases to gamma knife radiosurgery.
PubMed 文献 · Eur Radiol · 2022-01-03

该回顾性研究纳入137例肺癌脑转移患者共213个病灶,开发并验证基于多模态MRI的影像组学方法预测伽玛刀放射外科治疗后的反应。将瘤周水肿影像组学特征加入肿瘤核心特征后预测性能提升,影像组学列线图在主要队列AUC为0.930,在独立验证队列AUC为0.852。

要点

  • 基于治疗前多模态MRI的影像组学列线图可预测肺癌脑转移对伽玛刀治疗的反应,主要队列AUC为0.930。
  • 将瘤周水肿影像组学特征加入肿瘤核心特征后,主要队列AUC由0.750提升至0.848(p < 0.001)。
  • 纹理特征在预测任务中贡献约80%,其中灰度共生矩阵特征占40%。

核心结论

  • 基于多模态MRI的影像组学模型能够预测肺癌脑转移瘤对伽玛刀放射外科治疗的反应。

研究设计与样本

  • 回顾性分析2017年1月至2020年11月接受伽玛刀放射外科治疗的137例肺癌脑转移患者共213个病灶,按治疗时间分为主要队列(102例患者、173个病灶)和独立验证队列(35例患者、40个病灶);治疗反应依据神经肿瘤脑转移反应评估标准,使用治疗前和3个月随访MRI图像定义。

关键影像表现/征象

  • 从治疗前多模态MRI图像中使用随机森林提取有价值的影像组学特征。
  • 将瘤周水肿影像组学特征加入肿瘤核心影像组学特征后,主要队列预测性能AUC为0.848,优于单独使用肿瘤核心特征的AUC 0.750(p < 0.001)。
  • 所选影像组学特征中纹理特征在预测任务中贡献约80%,灰度共生矩阵特征占40%。

诊断标准与关键数值

  • 主要队列中影像组学列线图的AUC为0.930,C-index为0.930,特异度83.1%,敏感度87.3%。
  • 验证队列中影像组学列线图的AUC为0.852,C-index为0.848,特异度84.2%,敏感度76.2%。
  • 性别(p = 0.018)、组织学亚型(p = 0.009)、表皮生长因子受体突变(p = 0.034)和靶向药物治疗(p = 0.021)与治疗后反应显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop and validate a multimodality MRI-based radiomics approach to predicting the posttreatment response of lung cancer brain metastases (LCBM) to gamma knife radiosurgery (GKRS).

METHODS: We retrospectively analyzed 213 lesions from 137 patients with LCBM who received GKRS between January 2017 and November 2020. The data were divided into a primary cohort (102 patients with 173 lesions) and an independent validation cohort (35 patients with 40 lesions) according to the time of treatment. Benefit result was defined using pretreatment and 3-month follow-up MRI images based on the Response Assessment in Neuro-Oncology Brain Metastases criteria. Valuable radiomics features were extracted from pretreatment multimodality MRI images using random forests. Prediction performance among the radiomics features of tumor core (RFTC) and radiomics features of peritumoral edema (RFPE) together was evaluated separately. Then, the random forest radiomics score and nomogram were developed through the primary cohort and evaluated through an independent validation cohort. Prediction performance was evaluated by ROC curve, calibration curve, and decision curve.

RESULTS: Gender (p = 0.018), histological subtype (p = 0.009), epidermal growth factor receptor mutation (p = 0.034), and targeted drug treatment (p = 0.021) were significantly associated with posttreatment response. Adding RFPE to RFTC showed improved prediction performance than RFTC alone in primary cohort (AUC = 0.848 versus AUC = 0.750; p < 0.001). Finally, the radiomics nomogram had an AUC of 0.930, a C-index of 0.930 (specificity of 83.1%, sensitivity of 87.3%) in primary cohort, and an AUC of 0.852, a C-index of 0.848 (specificity of 84.2%, sensitivity of 76.2%) in validation cohort.

CONCLUSIONS: Multimodality MRI-based radiomics models can predict the posttreatment response of LCBM to GKRS.

KEY POINTS: • Among the selected radiomics features, texture features basically contributed the dominant force in prediction tasks (80%), especially gray-level co-occurrence matrix features (40%). • Adding RFPE to RFTC showed improved prediction performance than RFTC alone in primary cohort (AUC = 0.848 versus AUC = 0.750; p < 0.001). • The multimodality MRI-based radiomics nomogram showed high accuracy for distinguishing the posttreatment response of LCBM to GKRS (AUC = 0.930, in primary cohort; AUC = 0.852, in validation cohort).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Jiang, Wang, Han, et al. Multimodality MRI-based radiomics approach to predict the posttreatment response of lung cancer brain metastases to gamma knife radiosurgery. Eur Radiol. 2022. PMID: 34978579. doi:10.1007/s00330-021-08368-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。